Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

For all the hype surrounding weight loss injections, including Ozempic and Mounjaro, the elephant in the slimming room remains: what happens when you stop taking the injections? Wellness coach ...

Five GLP-1RAs are available in the UK-dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide, which is the active ingredient in Ozempic and Wegovy. Article continues below Ozempic is ...

Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and Wegovy. The medications have skyrocketed in price and popularity ...

Now, let's get to the news: Blue Cross Blue Shield of Massachusetts, the state's largest commercial health insurer, is rolling back its coverage of GLP-1 drugs like Ozempic and Wegovy for weight loss.

Weight-loss drugs can be life-changing for people who have struggled to lose weight, however, some people who take them experience unpleasant and concerning side effects. In 2024, roughly 5 per ...

But as a doctor I am very concerned that the mad scramble to get hold of semaglutide (brand names Ozempic and Wegovy) and tirzepatide (Mounjaro) has led to a Wild West market, where it's easy to ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medications, such as Ozempic and Wegovy, for millions of Medicare ...